Oct 28 (Reuters) - A European Medicines Agency (EMA) committee on Friday recommended adding heavy menstrual bleeding as a side effect of mRNA COVID-19 vaccines made by Moderna (MRNA.O), as well as partners Pfizer (PFE.N) and BioNTech (22UAy.DE).
Reports of heavy periods - bleeding characterised by increased volume and/or duration that interferes with the quality of life - have been observed during clinical trials, from cases in the real world and in medical literature, the EMA said.
The cases - which have mostly been non-serious and temporary in nature - have been reported after the first, second and booster doses of Pfizer-BioNTech's Comirnaty and Moderna's Spikevax, it added.
The regulator has now concluded that there is at least a "reasonable possibility" that heavy menstrual bleeding is causally associated with these vaccines.
Menstrual disorders can occur due to a range of reasons, including underlying medical conditions as well as stress and tiredness. Health authorities have highlighted that cases have also been reported following COVID-19 infection.
Our Standards: The Thomson Reuters Trust Principles.
"heavy" - Google News
October 28, 2022 at 06:24PM
https://ift.tt/3uT4RhM
EU regulator recommends adding heavy periods to side effects of mRNA COVID shots - Reuters
"heavy" - Google News
https://ift.tt/DxsVJAt
https://ift.tt/oDIF8Um
heavy
Bagikan Berita Ini
0 Response to "EU regulator recommends adding heavy periods to side effects of mRNA COVID shots - Reuters"
Post a Comment